# HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
> **ANDA210663** · Abbreviated New Drug Application (Generic) · Sponsor: SANKALP LIFECARE · Approved 2019-06-11
## Drug
- **FDA Application Number:** ANDA210663
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- **Generic name:** Homatropine Methylbromide
- **Active ingredients:** HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANKALP LIFECARE
- **First approval:** 2019-06-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210663)
---
*AI Analytics · CC0 1.0*